retatrutide phase 2 trial results weight loss 🚨 is out: 24.2% mean and a quarter lost >30%! Women lost more weight than men. #ADA2023 was like drinking from a fire hose for emerging anti-obesity Triple hormone receptor agonist retatrutide

Whether you're starting fresh or rebuilding consistency, this plan helps you eat more, burn more, and feel better without giving up food you love

Eli Lillys orforglipron represents a breakthrough in this transition as the first oral small-molecule GLP-1RA to complete Phase 3 trials

In February 2025, the FDA announced that the shortage of semaglutide injectable products (Ozempic, Wegovy) has been resolved, Dulaglutide (Trulicity) shortage resolved in June 2025

Blood glucose monitoring becomes particularly important during this period, and your healthcare team may need to adjust other diabetes medications to maintain control

Some metabolic supplements, often dubbed faux-zempic, are marketed to mimic GLP-1 medications, though their mechanisms and effectiveness differ, says Dr

[DOI] [PubMed] [Google Scholar] 30.Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF